Related Experiment Video
Updated: Apr 12, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Design and Validation of FRESH, a Drug Discovery Paradigm Resting on Robust Chemical Synthesis
Qi Shi1, Thomas M Kaiser1, Zackery W Dentmon1
1Department of Chemistry, Emory University , Atlanta, Georgia 30322, United States.
Abstract:
A method capable of identifying novel synthetic targets for small molecule lead optimization has been developed. The FRESH (FRagment-based Exploitation of modular Synthesis by vHTS) approach relies on a multistep synthetic route to a target series of compounds devised by a close collaboration between synthetic and computational chemists. It combines compound library generation, quantitative structure-acitvity relationship construction, fragment processing, virtual high throughput screening and display of results within the Pipeline Pilot framework. Outcomes enumerate tailored selection of novel synthetic targets with improved potency and optimized physical properties for an emerging compound series. To validate the application of FRESH, three retrospective case studies have been performed to pinpoint reported potent analogues. One prospective case study was performed to demonstrate that FRESH is able to capture additional potent analogues.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
In Vitro Drug Release Testing: Overview, Development and Validation
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Preclinical Development: Overview

